Coronavirus: As COVID-19 cases surge, expert lists down top 5 symptoms to watch out for - Times of India

The sudden rise in coronavirus cases has become a source of great concern. Just when we thought things were going back to normal, the BA.2 subvariant of COVID's Omicron is wreaking havoc in many parts of the world, leaving experts and doctors highly concerned.

"Omicron is sweeping the world. It is the latest variant of concern and about 86% of the sequences that are available from the last four weeks are the BA.2 sub-lineage. The rest are BA.1," said Maria Van Kerkhove, the WHO's technical lead on COVID-19. The global health agency has declared the sub-lineage to be the dominant strain around the globe, which is said to be driving the current surge in Asia and Europe.

Also read: Coronavirus variant: As BA.2 is on rise, know who should be more worried about BA.2 infection

Prof. Tim Spector of UK's ZOE symptoms study app took to twitter to address the uptick in COVID cases in the United Kingdom. "Most cold symptoms are now Omicron infections in the U.K. as record levels continue and we approach 300000 cases per day with no sign of a slowdown- no sign of any public health messaging but thanks for logging with Zoe!"

Additionally, he mentions that even with the rise in the number of cases, there are still "no government warnings that the top five symptoms of COVID-19 are still like a cold - even in the elderly and more vulnerable". Let us take a look at what these 5 dominant symptoms are.

Comments

Post a Comment

Popular posts from this blog

Anand Swaminath, MD, Discusses Rationale for Assessing SBRT Vs CRT in Central/Peripheral NSCLC - Cancer Network

Image
In recent years, health care providers have become increasingly concerned around the use of stereotactic radiation for lung cancers that are found near the center of a patient's chest, according to an expert. As a result, Anand Swaminath, MD, and colleagues, wanted not only to assess the efficacy, but also the safety of stereotactic body radiation in a group of patients with inoperable non-small cell lung cancer (NSCLC). Swaminath, an associate professor, clinician scientist, and radiation oncologist at Juravinski Cancer Centre in Ontario, Canada, spoke with CancerNetwork ® during the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting and discussed why they compared stereotactic body radiotherapy with a 3-week conventional hypofractionated radiotherapy regimen for patients with stage I medically inoperable NSCLC. Transcript: The standard of care right now for stage I lung cancer is to have surgery. But radiation is a suitable alternative to surgery, and a specifi...
Read more